Biosimilars In EU Seeing Reduced Clinical Data Requirements
This article was originally published in PharmAsia News
Executive Summary
After a 'slightly conservative approach' at the beginning, 'we are now getting to the meat of what we can do with biosimilars,' the European Medicine Association's Head of Quality Peter Richardson says.